Cerovene, Inc. v. Fukuzyu Pharmaceutical Co., Ltd.

District Court, S.D. New York·Decided May 12, 2025·No. 1:24-cv-00464·Unknown

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

CEROVENE, INC. and DR. REDDY’S LABORATORIES, INC., Plaintiffs, y No. 24-CV-464 (RA) FUKUZYU PHARMACEUTICAL CoO., ORDER LTD., Defendant.

RONNIE ABRAMS, United States District Judge: It has been reported to the Court that this case has been settled in principle. Accordingly, it is hereby: ORDERED that the above-captioned action is discontinued without costs to any party and without prejudice to restoring the action to this Court’s docket if the application to restore the action is made within thirty (30) days. Any application to reopen this action must be filed within thirty (30) days of this order, and any application filed thereafter may be denied solely on that basis. If the parties seek to have the Court retain jurisdiction to enforce a settlement agreement, the terms of the agreement must be placed on the public record and “so ordered” by the Court within the same thirty-day period. See Hendrickson v. United States, 791 F.3d 354, 358 (2d Cir. 2015). The Clerk of Court is respectfully directed to close this case. SO ORDERED. Dated: May 12, 2025 ff f New York, New York J Ronnie Abrams United States District Judge

Free access — add to your briefcase to read the full text and ask questions with AI

Cerovene, Inc. v. Fukuzyu Pharmaceutical Co., Ltd., (S.D.N.Y. 2025).

Cerovene, Inc. v. Fukuzyu Pharmaceutical Co., Ltd. (Cerovene, Inc. v. Fukuzyu Pharmaceutical Co., Ltd.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hendrickson v. United States
791 F.3d 354 (Second Circuit, 2015)